Literature DB >> 23818055

Porphyromonas gingivalis lipopolysaccharide activates canonical Wnt/β-catenin and p38 MAPK signalling in stem cells from the apical papilla.

Jia Wang1, Jiewen Dai, Bin Liu, Shensheng Gu, Lan Cheng, Jingping Liang.   

Abstract

As dental precursor cells, stem cells from the apical papilla (SCAP) are capable of forming roots and undergoing apexogenesis, which are impaired upon exposure to bacterial infection. Porphyromonas gingivalis is a common Gram-negative bacterium that is involved in pulpal and periapical infection. The purpose of this study was to investigate the effects of P. gingivalis lipopolysaccharide (LPS) on the Wnt/β-catenin and p38 mitogen-activated protein kinase (MAPK) signalling pathways in SCAP. As indicated by the IL-1β and TNF-α mRNA levels, P. gingivalis LPS induced the expression of pro-inflammatory cytokines in a dose-dependent manner. In addition, activation of the p38 MAPK and Wnt/β-catenin pathways was confirmed by the augmentation of phospho-p38 and β-catenin protein expression and increased expression of c-myc and cyclin D1 mRNA. Despite no significant increase in β-catenin mRNA expression, increased phosphorylation of glycogen synthase kinase (GSK)-3β suggested that GSK-3β was responsible for the accumulation of β-catenin in the cytoplasm and translocation to the nucleus. Previous studies have shown that GSK-3β plays a critical role in crosstalk between the Wnt/β-catenin and p38 MAPK pathways. In the present study, we showed that the level of p38 phosphorylation decreased upon pretreatment with a p38 MAPK inhibitor for 1 h before stimulating SCAP with 10 μg/ml P. gingivalis LPS. However, the levels of GSK-3β and β-catenin phosphorylation in the cytoplasm and nucleus were not significantly altered. Our results suggest that the p38 MAPK and canonical Wnt/β-catenin signalling pathways are activated by P. gingivalis LPS in SCAP, but we have no evidence that p38 MAPK is upstream of GSK-3β in the Wnt/β-catenin signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818055     DOI: 10.1007/s10753-013-9679-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  43 in total

1.  Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide.

Authors:  M Miyauchi; S Sato; S Kitagawa; M Hiraoka; Y Kudo; I Ogawa; M Zhao; T Takata
Journal:  Histochem Cell Biol       Date:  2001-07       Impact factor: 4.304

2.  WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line.

Authors:  Haeyong Lee; Sungmin Bae; Byoung Whui Choi; Yoosik Yoon
Journal:  Immunopharmacol Immunotoxicol       Date:  2011-06-24       Impact factor: 2.730

3.  Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients.

Authors:  Caroline Bergenfelz; Catharina Medrek; Elin Ekström; Karin Jirström; Helena Janols; Marlene Wullt; Anders Bredberg; Karin Leandersson
Journal:  J Immunol       Date:  2012-04-30       Impact factor: 5.422

4.  Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation.

Authors:  Richard P Darveau; Saman Arbabi; Iris Garcia; Brian Bainbridge; Ronald V Maier
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 5.  On the causes of persistent apical periodontitis: a review.

Authors:  P N R Nair
Journal:  Int Endod J       Date:  2006-04       Impact factor: 5.264

6.  Wnt5a is expressed in murine and human atherosclerotic lesions.

Authors:  Mark A Christman; Douglas J Goetz; Eric Dickerson; Kelly D McCall; Christopher J Lewis; Fabian Benencia; Mitchell J Silver; Leonard D Kohn; Ramiro Malgor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

7.  Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells.

Authors:  Prajna Mishra; Subramanian Senthivinayagam; Ajay Rana; Basabi Rana
Journal:  J Mol Signal       Date:  2010-07-16

Review 8.  Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine.

Authors:  G T-J Huang; S Gronthos; S Shi
Journal:  J Dent Res       Date:  2009-09       Impact factor: 6.116

9.  Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.

Authors:  Iris Gehrke; Rajesh Kumar Gandhirajan; Karl-Anton Kreuzer
Journal:  Eur J Cancer       Date:  2009-09-02       Impact factor: 9.162

Review 10.  The Wnts.

Authors:  Jeffrey R Miller
Journal:  Genome Biol       Date:  2001-12-28       Impact factor: 13.583

View more
  5 in total

1.  Noncanonical activation of β-catenin by Porphyromonas gingivalis.

Authors:  Yun Zhou; Maryta Sztukowska; Qian Wang; Hiroaki Inaba; Jan Potempa; David A Scott; Huizhi Wang; Richard J Lamont
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

2.  JAK3 restrains inflammatory responses and protects against periodontal disease through Wnt3a signaling.

Authors:  Lanhai Lü; Lan Yakoumatos; Junling Ren; Xiaoxian Duan; Huaxin Zhou; Zhen Gu; Muddasir Mohammed; Silvia M Uriarte; Shuang Liang; David A Scott; Richard J Lamont; Huizhi Wang
Journal:  FASEB J       Date:  2020-05-20       Impact factor: 5.191

3.  Circulating miRNAs as Epigenetic Mediators of Periodontitis and Preeclampsia Association.

Authors:  Wangmeng Zhang; Qishan Wu; Juan Su; Wenwen Wang; Xudong Zhao; Ping Cao
Journal:  Dis Markers       Date:  2022-07-11       Impact factor: 3.464

Review 4.  Toll-Like Receptors and Dental Mesenchymal Stromal Cells.

Authors:  Oleh Andrukhov
Journal:  Front Oral Health       Date:  2021-04-16

Review 5.  Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review).

Authors:  Qingtao Zhang; Jian Yu; Qiuqiu Chen; Honghai Yan; Hongjiang Du; Wenjing Luo
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.